Profile
GRTX VRTX REGN VRNA ARGX ALNY
Company Name Galera Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.66M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO J. Mel Sorensen Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
GRTX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
GRTX VRTX REGN VRNA ARGX ALNY
Last Close $0.023 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.05 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.02 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -54 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 15 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
GRTX VRTX REGN VRNA ARGX ALNY
1 Month Return 38.06 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -4.56 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -4.17 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -45.24 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -50 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -42.64 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GRTX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
GRTX VRTX REGN VRNA ARGX ALNY
Asset Growth -61.36 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -1383.78 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 72.82 % 9.09 % -131.37 % 24.59 %
Net Income Growth 67.91 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 88.89 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 83.42 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -2143.49 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 57.06 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 72.92 % - -143.33 % -107.98 %
Operating 3 Year CFG 91.56 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 88.18 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -1345.85 % -100 % 40.15 % 97.08 %
EPS Growth 73.68 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 73.68 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 10.7 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -16.92 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -193.74 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -5160.2 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 11983.92 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 72.96 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
GRTX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -179.65 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 6.17 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -227.07 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 89.86 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 8.83 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.02 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.02 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 4.54 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.71 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -0.93 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -0.93 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
GRTX VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $-0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 0% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.02B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.02B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -0.35 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
GRTX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.15B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $-0.14B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.15B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.01B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
GRTX VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to GRTX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
VXF Vanguard Extended Market Index Fund 0 216.28
IWC iShares Micro-Cap ETF 0.00336 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 164.01
QQQS Invesco NASDAQ Future Gen 200 ETF 0.339 35.1624
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000207348 16.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 164.02
VEMPX Vanguard Extended Market Index InstlPlus 0 404.75
Unlock